Immediate versus staged revascularisation of non-culprit arteries in patients with acute coronary syndrome: a systematic review and meta-analysis

Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vriesendorp, P. A., Wilschut, J. M., Diletti, R., Daemen, J., Kardys, I., Zijlstra, F., Van Mieghem, N. M., Bennett, J., Esposito, G., Sabate, M., den Dekker, W. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474746/
https://www.ncbi.nlm.nih.gov/pubmed/35536483
http://dx.doi.org/10.1007/s12471-022-01687-7
Descripción
Sumario:Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s12471-022-01687-7) contains supplementary material, which is available to authorized users.

Ejemplares similares